TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Liabilities | ₹155 Cr | ₹88 Cr | ₹62 Cr | ₹13 Cr |
What is the latest Total Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹13 Cr |
How is Total Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 77.20 | |
| Mar2024 | ₹88 Cr | 40.45 | |
| Mar2023 | ₹62 Cr | 385.49 | |
| Mar2022 | ₹13 Cr | - | |
Compare Total Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹302.3 Cr | 0.7% | -17.2% | -4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.7% |
-17.2% |
-4.6% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses